4
Changes in Ownership
Aurinia Pharmaceuticals Inc. Filed Acc 0001628280-21-010021
Chief Business Officer acquired 20,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Martin Michael Robert Chief Business Officer | 2021-05-11 | Option exercise | +20,000 | $3.02 | $60,400 | 221,861 | D: show line 1 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Martin Michael Robert Chief Business Officer | 2021-05-11 | Option exercise · Option Grant (right to buy) | −20,000 | 0 | D: show line 2 in the form |
Loading xslF345X03/wf-form4_162085139436066.xml…